keyword
https://read.qxmd.com/read/38650920/second-line-treatment-of-pancreatic-adenocarcinoma-shedding-light-on-new-opportunities-and-key-talking-points-from-clinical-trials
#1
REVIEW
Robin Imperial, Osama Mosalem, Umair Majeed, Nguyen H Tran, Mitesh J Borad, Hani Babiker
Despite improvements in overall cancer mortality, deaths related to pancreatic cancer continue to rise. Following first-line treatment, second-line options are significantly limited. Classically, first-line treatment consisted of either gemcitabine or 5-fluorouracil based systemic chemotherapy. Upon progression of disease or recurrence, subsequent second-line treatment is still gemcitabine or 5-fluorouracil based chemotherapy, depending on what was used in the first line and the timing of progression or recurrence...
2024: Clinical and Experimental Gastroenterology
https://read.qxmd.com/read/38650043/correlation-of-lesion-severity-with-bacterial-changes-in-treponeme-associated-hoof-disease-from-free-roaming-wild-elk-cervus-canadensis
#2
JOURNAL ARTICLE
Jennifer H Wilson-Welder, Sushan Han, Darrell O Bayles, David P Alt, Carly Kanipe, Kyle Garrison, Kristin G Mansfield, Steven C Olsen
BACKGROUND: Treponeme-Associated Hoof Disease (TAHD) is a polybacterial, multifactorial disease affecting free-ranging wild elk (Cervus canadensis) in the Pacific Northwest. Previous studies have indicated a bacterial etiology similar to digital dermatitis in livestock, including isolation of Treponema species from lesions. The lesions appear to progress rapidly from ulcerative areas in the interdigital space or along the coronary band to severe, ulcerative, necrotic, proliferative lesions under-running the hoof wall, perforating the sole, and contributing to hoof elongation, deformity, and overgrowth...
April 22, 2024: Animal microbiome
https://read.qxmd.com/read/38641057/economic-evaluations-of-car-t-cell-therapies-for-hematologic-and-solid-malignancies-a-systematic-review
#3
REVIEW
Kednapa Thavorn, Emily Thompson, Srishti Kumar, Aliisa Heiskanen, Anubhav Agarwal, Harold Atkins, Risa Shorr, Terry Hawrysh, Kelvin Kar-Wing Chan, Justin Presseau, Daniel A Ollendorf, Ian D Graham, Jeremy M Grimshaw, Manoj Mathew Lalu, Surapon Nochaiwong, Dean A Fergusson, Brian Hutton, Doug Coyle, Natasha Kekre
OBJECTIVES: This study aims to systematically review evidence on the cost-effectiveness of chimeric antigen receptor (CAR)-T therapies for patients with cancer. METHODS: Electronic databases were searched in October 2022 and updated in September 2023. Systematic reviews, health technology assessments and economic evaluations that compared costs and effects of CAR-T therapy in cancer patients were included. Two reviewers independently screened studies, extracted data, synthesized results, and critically appraised studies using the Philips checklist...
April 17, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38638442/advancements-in-cancer-immunotherapies-targeting-cd20-from-pioneering-monoclonal-antibodies-to-chimeric-antigen-receptor-modified-t-cells
#4
REVIEW
Agnieszka Dabkowska, Krzysztof Domka, Malgorzata Firczuk
CD20 located predominantly on the B cells plays a crucial role in their development, differentiation, and activation, and serves as a key therapeutic target for the treatment of B-cell malignancies. The breakthrough of monoclonal antibodies directed against CD20, notably exemplified by rituximab, revolutionized the prognosis of B-cell malignancies. Rituximab, approved across various hematological malignancies, marked a paradigm shift in cancer treatment. In the current landscape, immunotherapies targeting CD20 continue to evolve rapidly...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638306/methods-for-integrating-trials-and-non-experimental-data-to-examine-treatment-effect-heterogeneity
#5
JOURNAL ARTICLE
Carly Lupton Brantner, Ting-Hsuan Chang, Trang Quynh Nguyen, Hwanhee Hong, Leon Di Stefano, Elizabeth A Stuart
Estimating treatment effects conditional on observed covariates can improve the ability to tailor treatments to particular individuals. Doing so effectively requires dealing with potential confounding, and also enough data to adequately estimate effect moderation. A recent influx of work has looked into estimating treatment effect heterogeneity using data from multiple randomized controlled trials and/or observational datasets. With many new methods available for assessing treatment effect heterogeneity using multiple studies, it is important to understand which methods are best used in which setting, how the methods compare to one another, and what needs to be done to continue progress in this field...
November 2023: Statistical Science: a Review Journal of the Institute of Mathematical Statistics
https://read.qxmd.com/read/38629814/early-evaluation-of-car-t-cell-therapy-response-in-r-r-dlbcl-patients-using-18-f-fdg-pet-ct
#6
JOURNAL ARTICLE
Kazuhiro Kitajima, Hiroyuki Yokoyama, Reona Wada, Yukihisa Tamaki, Kyoko Yoshihara, Katsuji Kaida, Satoshi Yoshihara, Koichiro Yamakado
OBJECTIVE: CD19-targeted chimeric antigen receptor T (CAR-T) cell therapy provides a durable response in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). The role of fluorine-18-fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed tomography (PET/CT) for early evaluation of responsein patients with that immunotherapy was evaluated. SUBJECTS AND METHODS: Three separate 18 F-FDG PET/CT examinations of 53 patients (29 males, 24 females; median 62 years old) with R/R DLBCL were conducted; before bridging therapy [time of decision (TD)], before CAR-T (tisagenlecleucel, n=37; lisocabtagenemaraleucel, n=16) infusion [time of CAR-T infusion (IT)], and one month (M1) after CAR-T infusion...
April 18, 2024: Hellenic Journal of Nuclear Medicine
https://read.qxmd.com/read/38624121/experimental-study-of-rotational-relaxation-for-d2-1-12-in-collisions-with-n2
#7
JOURNAL ARTICLE
Lin Mao, Jing Liu, Nurali Habibulla, Yongbao Qiu
The rotational relaxation behavior of D2(1,12) in a D2-N2 mixture was investigated using coherent anti-Stokes Raman scattering (CARS) technique. The rovibrational level v = 1 and J = 12 of D2 was selectively excited through stimulated Raman pumping while monitoring the temporal evolution of population for D2(1, J ≤ 12) molecules using time-resolved CARS spectroscopy. The results demonstrate that the rotational relaxation processes of D2(1,12) encompass both multi-quantum relaxation and continuous single-quantum relaxation...
April 21, 2024: Journal of Chemical Physics
https://read.qxmd.com/read/38622914/high-positive-predictive-value-22q11-2-microdeletion-screening-by-prenatal-cell-free-dna-testing-that-incorporates-fetal-fraction-amplification
#8
JOURNAL ARTICLE
Carly Hammer, Summer Pierson, Ashley Acevedo, James Goldberg, Thomas Westover, Devika Chawla, Brent Mabey, Dale Muzzey, Katherine Johansen Taber
OBJECTIVE: 22q11.2 deletion syndrome (DS) is a serious condition with a range of features. The small microdeletion causing 22q11.2DS makes it technically challenging to detect using standard prenatal cfDNA screening. Here, we assess 22q11.2 microdeletion clinical performance by a prenatal cfDNA screen that incorporates fetal fraction (FF) amplification. METHODS: The study cohort consisted of patients who received Prequel (Myriad Genetics, Inc.), a prenatal cfDNA screening that incorporates FF amplification, and met additional eligibility criteria...
April 15, 2024: Prenatal Diagnosis
https://read.qxmd.com/read/38622705/current-challenges-and-therapeutic-advances-of-car-t-cell-therapy-for-solid-tumors
#9
REVIEW
Tong Chen, Mingzhao Wang, Yanchao Chen, Yutao Liu
The application of chimeric antigen receptor (CAR) T cells in the management of hematological malignancies has emerged as a noteworthy therapeutic breakthrough. Nevertheless, the utilization and effectiveness of CAR-T cell therapy in solid tumors are still limited primarily because of the absence of tumor-specific target antigen, the existence of immunosuppressive tumor microenvironment, restricted T cell invasion and proliferation, and the occurrence of severe toxicity. This review explored the history of CAR-T and its latest advancements in the management of solid tumors...
April 15, 2024: Cancer Cell International
https://read.qxmd.com/read/38619630/preoperative-nun-score-serves-as-a-robust-predictor-of-overall-and-disease-specific-survivals-following-radical-surgery-for-gastric-cancer
#10
JOURNAL ARTICLE
Masayuki Urabe, Yasuhiro Okumura, Asami Okamoto, Shoh Yajima, Koichi Yagi, Hiroharu Yamashita, Yasuyuki Seto
PURPOSE: Methods to preoperatively stratify oncological risks associated with gastric cancer (GC) are limited. Host inflammatory parameters, i.e., serum C-reactive protein (CRP) and albumin levels, are known to be associated with outcomes. We examined the relationships between disease-specific mortality and four CRP-albumin-based indices (CRP-albumin ratio [CAR], modified Glasgow prognostic score [mGPS], Osaka prognostic score [OPS], and NUn score) preoperatively measured in cases with resectable GC...
April 15, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38619337/indirect-impact-of-sars-cov-2-pandemic-on-incidence-of-maternal-primary-cytomegalovirus-and-toxoplasma-gondii-infection-in-pregnancy
#11
JOURNAL ARTICLE
Maria Viola Vasarri, Federica Fernicola, Francesca Arienti, Anna Carli, Elisabetta Colciago, Anna Locatelli, Michele Trotta, Angelica Procopio, Lorenzo Zammarchi, Sara Ornaghi
OBJECTIVE: Public health interventions promoted during the SARS-CoV-2 pandemic to control viral spread have impacted the occurrence of other communicable disease. Yet no studies have focused on perinatal infections with the potential for neonatal sequelae, including cytomegalovirus (CMV) and Toxoplasma gondii (TG). Here we investigate whether incidence rates of maternal primary CMV and TG infection in pregnancy were affected by the implementation of pandemic-related public health measures...
April 15, 2024: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/38610967/innovative-combinations-cellular-therapies-and-bispecific-antibodies-for-chronic-lymphocytic-leukemia-a-narrative-review
#12
REVIEW
Andrea Visentin, Sara Frazzetto, Livio Trentin, Annalisa Chiarenza
In the last few years, several agents targeting molecules that sustain the survival and the proliferation of chronic lymphocytic leukemia (CLL) cells have become clinically available. Most of these drugs target surface proteins, such as CD19 or CD20, via monoclonal or bispecific monoclonal antibodies (BsAbs), CAR T cells, intracellular proteins like BTK by using covalent or non-covalent inhibitors or BCL2 with first or second generation BH3-mimetics. Since the management of CLL is evolving quickly, in this review we highlighted the most important innovative treatments including novel double and triple combination therapies, CAR T cells and BsAbs for CLL...
March 26, 2024: Cancers
https://read.qxmd.com/read/38610956/optimising-patient-outcomes-in-tongue-cancer-a-multidisciplinary-approach
#13
REVIEW
Jasper de Boer, Rebecca Barnett, Anthony Cardin, Michelle Cimoli, Lauren Davies, Clare Delany, Benjamin J Dixon, Sue M Evans, Michael W Findlay, Carly Fox, Maria Ftanou, Christopher D Hart, Megan Howard, Tim A Iseli, Andrea Jackson, Sevastjan Kranz, Brian H Le, Ernest Lekgabe, Rachel Lennox, Luke S McLean, Paul J Neeson, Sweet Ping Ng, Lorraine A O'Reilly, Anand Ramakrishnan, David Rowe, Carrie Service, Ankur Singh, Alesha A Thai, Albert Tiong, Tami Yap, David Wiesenfeld
A multidisciplinary approach to the management of tongue cancer is vital for achieving optimal patient outcomes. Nursing and allied health professionals play essential roles within the team. We developed symposia comprising a series of online lectures offering a detailed perspective on the role each discipline and consumer perspective has in the management of patients with tongue cancer. The topics, including epidemiology and prevention, diagnosis, treatment planning, surgery, adjuvant care, and the management of recurrent or metastatic disease, were thoroughly examined...
March 26, 2024: Cancers
https://read.qxmd.com/read/38610486/coupling-different-road-traffic-noise-models-with-a-multilinear-regressive-model-a-measurements-independent-technique-for-urban-road-traffic-noise-prediction
#14
JOURNAL ARTICLE
Domenico Rossi, Antonio Pascale, Aurora Mascolo, Claudio Guarnaccia
Road traffic noise is a severe environmental hazard, to which a growing number of dwellers are exposed in urban areas. The possibility to accurately assess traffic noise levels in a given area is thus, nowadays, quite important and, on many occasions, compelled by law. Such a procedure can be performed by measurements or by applying predictive Road Traffic Noise Models (RTNMs). Although the first approach is generally preferred, on-field measurement cannot always be easily conducted. RTNMs, on the contrary, use input information (amount of passing vehicles, category, speed, among others), usually collected by sensors, to provide an estimation of noise levels in a specific area...
April 3, 2024: Sensors
https://read.qxmd.com/read/38608709/the-enchanting-canvas-of-car-technology-unveiling-its-wonders-in-non-neoplastic-diseases
#15
REVIEW
Jinhui Shu, Wei Xie, Zhaozhao Chen, Rienk Offringa, Yu Hu, Heng Mei
Chimeric antigen receptor (CAR) T cells have made a groundbreaking advancement in personalized immunotherapy and achieved widespread success in hematological malignancies. As CAR technology continues to evolve, numerous studies have unveiled its potential far beyond the realm of oncology. This review focuses on the current applications of CAR-based cellular platforms in non-neoplastic indications, such as autoimmune, infectious, fibrotic, and cellular senescence-associated diseases. Furthermore, we delve into the utilization of CARs in non-T cell populations such as natural killer (NK) cells and macrophages, highlighting their therapeutic potential in non-neoplastic conditions and offering the potential for targeted, personalized therapies to improve patient outcomes and enhanced quality of life...
April 5, 2024: Med
https://read.qxmd.com/read/38607646/targeting-gprc5d-in-multiple-myeloma
#16
REVIEW
Shatha Elemian, Samer Al Hadidi
INTRODUCTION: The prognosis of multiple myeloma (MM) continues to improve. Recent progress in therapies, using immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and anti-CD38 monoclonal antibodies, has greatly improved patients' outcomes. Despite these advancements, relapses still happen often, and patients can become resistant to the usual treatments. Newer treatments, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies (BsAbs) targeting B-cell maturation antigen (BCMA), have resulted in excellent outcomes in patients with limited treatment options...
April 16, 2024: Expert Review of Anticancer Therapy
https://read.qxmd.com/read/38604784/-exploration-and-practice-of-novel-models-of-cellular-therapy-and-hematopoietic-stem-cell-transplantation
#17
JOURNAL ARTICLE
X Zhang, R H Huang
Hematopoietic stem cell transplantation provides an effective cure for various hematological diseases, especially malignant hematological diseases, its treatment system has been continuously optimized, the source of donors has been expanding, the indications have been expanding, and the therapeutic effect has also made breakthroughs to a certain extent. At present, the status of hematopoietic stem cell transplantation technology in most hematological diseases is still unshakable, but the recurrence of the primary disease and complications related to hematopoietic stem cell transplantation are still two major clinical challenges that affect the long-term survival and quality of life of patients...
February 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/38601550/simulated-and-measured-piezoelectric-energy-harvesting-of-dynamic-load-in-tires
#18
JOURNAL ARTICLE
Henrik Staaf, Simon Matsson, Sobhan Sepheri, Elof Köhler, Kaies Daoud, Fredrik Ahrentorp, Christian Jonasson, Peter Folkow, Leena Ryynänen, Mika Penttila, Cristina Rusu
From 2007 in US and from 2022 in EU it is mandatory to use TPMS monitoring in new cars. Sensors mounted in tires require a continuous power supply, which currently only is from batteries. Piezoelectric energy harvesting is a promising technology to harvest energy from tire movement and deformation to prolong usage of batteries and even avoid them inside tires. This study presents a simpler method to simultaneous model the tire deformation and piezoelectric harvester performance by using a new simulation approach - dynamic bending zone...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38594105/advanced-practice-nursing-and-car-t-cell-therapy-opportunities-challenges-and-future-directions
#19
JOURNAL ARTICLE
Daniel Kisielewski, Matthias Naegele
OBJECTIVES: Chimeric antigen receptor (CAR)-T cell therapy is a new treatment for patients with myeloma and other B cell malignancies where advanced practice nurses (APN) can make a great contribution. The aim of this review is to identify key aspects of current literature relevant to APNs working with this population. METHODS: Discussion of selected peer-reviewed literature and best practice guidelines found through electronic database searches (CINAHL, MEDLINE)...
April 8, 2024: Seminars in Oncology Nursing
https://read.qxmd.com/read/38591322/usefulness-of-heart-failure-categories-based-on-left-ventricular-ejection-fraction
#20
JOURNAL ARTICLE
Malin Christersson, Stefan Gustafsson, Erik Lampa, Matilda Almstedt, Thomas Cars, Johan Bodegård, Gabriel Arefalk, Johan Sundström
BACKGROUND: Heart failure guidelines have recently introduced a narrow category with mildly reduced left ventricular ejection fraction (LVEF) (heart failure with mildly reduced ejection fraction; LVEF 41%-49%) between the previous categories of reduced (heart failure with reduced ejection fraction; LVEF ≤40%) and preserved (heart failure with preserved ejection fraction; LVEF ≥50%) ejection fraction. Grouping of continuous measurements into narrow categories can be questioned if their variability is high...
April 9, 2024: Journal of the American Heart Association
keyword
keyword
69291
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.